1. Arias KM, Aureden K, Bartley J, Burns L, Creen C, Lundstrom T, et al. Guide to the elimination of Methicillin-resistant Staphylococcus aureus (MRSA) transmission in hospital settings. 2007. Available from: http://www.apic.org/AM/Template.cfm?Section=APIC_Elimination_Guides&Template=/CM/HTMLDisplay.cfm&ContentID=14743. Accessed June 22, 2010.
2. Invasive Methicillin-resistant Staphylococcus aureus infections in the United States;Klevins;JAMA,2007
3. Siegel JD, Rhineheart E, Jackson M, Linda C, and the Healthcare Infection Control Practices Advisory Committee. Management of multi-drug resistant organisms in healthcare settings, 2006. Available from: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed June 22, 2010.
4. Pfizer Inc. New research estimates MRSA infections cost U.S. hospitals $3.2 to $4.2 billion annually. Infect Control Today 2005. Available from: http://www.infectioncontroltoday.com/hotnews/55h168584264313.html. Accessed June 22, 2010.
5. Society for Healthcare Epidemiology of America. SHEA guidelines for preventing nosocomial transmission of multi-drug resistant strains of Staphylococcus aureus and Enterococcus;Muto;Infect Control Hosp Epidemiol,2003